Christian Conrad Glaser, D.O. Internal Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 29955 Three Notch Rd Ste 100, Charlotte Hall, MD 20622 Phone: 301-290-5300 |
Dr. Robert L Miles Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 37767 Market Dr, Charlotte Hall, MD 20622 Phone: 301-373-7900 Fax: 301-373-6900 |
Natasha Johnson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 37767 Market Dr, Charlotte Hall, MD 20622 Phone: 301-373-7900 Fax: 301-373-6900 |
Dr. Anpalakan Sathasivam, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 37767 Market Dr, Second Floor, Charlotte Hall, MD 20622 Phone: 301-884-7330 |
Dr. Shelsea Danai Mccarthy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 37767 Market Dr Unit 2, Charlotte Hall, MD 20622 Phone: 301-884-0278 |
Mary Kramer, Internal Medicine Medicare: Medicare Enrolled Practice Location: 37767 Market Dr, Charlotte Hall, MD 20622 Phone: 301-884-7322 Fax: 301-884-8663 |
News Archive
A rare parasitic disease, which normally only is transmitted by contaminated water, has been shown to be transmitted by gay sex between hiv-positive men. In the industrial world the disease is virtually absent, but from now on that could change.
The study, "Influence of early day care exposure on total IgE levels through age 3 years" can be found in the Articles in Press section of the JACI Web site, http://www.jacionline.org. The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).
The pledging of $5bn for survivors of the tsunami only three weeks after the event is an impressive expression of global concern, and is likely to meet most of the vital needs for survival.
The Minneapolis Heart Institute Foundation, Minneapolis Heart Institute at Abbott Northwestern Hospital, Mayo Clinic, and University of Minnesota are convening The Women and Heart Disease Summit in Minneapolis.
Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.
› Verified 7 days ago